Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson's Disease
- PMID: 39331108
- PMCID: PMC11492103
- DOI: 10.3233/JPD-240181
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson's Disease
Abstract
Background: Whether body weight changes are associated with Parkinson's disease (PD) mortality remains uncertain.
Objective: To investigate the association between changes in body mass index (BMI) and all-cause mortality in patients with PD.
Methods: This nationwide cohort study enrolled 20,703 individuals with new-onset PD (ICD-10 code: G20 and a rare intractable disease registration code: V124) who underwent health screening program by the Korean National Health Insurance Service within two years from pre- and post-PD diagnosis. We identified nine BMI change groups based on three BMI status: underweight (BMI < 18.5 kg/m2), normal or overweight (18.5 kg/m2≤BMI < 25 kg/m2), and obese (BMI≥25 kg/m2).
Results: Of 20,703 individuals, 3,789 (18.0%) died during the follow-up period. Excessive weight loss to underweight in the obese group (hazard ratio [HR] = 3.36, 95% CI:1.60-7.08), weight loss in the normal to overweight group (HR = 2.04, 95% CI:1.75-2.39), sustained underweight status (HR = 2.05, 95% CI:1.67-2.52), and weight gain from underweight to normal or overweight (HR = 1.52, 95% CI:1.15-2.02) were associated with increased mortality. Sustained obese status (HR = 0.80, 95% CI:0.74-0.87) and weight gain in the normal to overweight group (HR = 0.82, 95% CI:0.71-0.95) were associated with reduced mortality.
Conclusions: We found that BMI change at diagnosis was associated with mortality in patients with PD. Specifically, being underweight either before or after diagnosis as well as experiencing weight loss, were associated with increased mortality. These findings provide valuable insights for weight management planning in PD, highlighting the importance of individualized approach that consider pre-diagnosis BMI.
Keywords: Body mass index; Parkinson’s disease; cohort study; mortality; weight change.
Plain language summary
Whether body weight changes are associated with Parkinson’s disease (PD) mortality remains uncertain. This study looked at how changes in body weight affect the chances of survival in people who have recently been diagnosed with PD. We followed 20,703 individuals who were newly diagnosed with this condition and checked their weight changes before and after their diagnosis. We found that people with PD who lost a lot of weight to become underweight had a higher risk of dying during our study. Similarly, those who were already underweight and remained so also had a higher mortality risk. On the other hand, people who maintained a weight or gained a small amount of weight after their diagnosis had the lowest risk of dying. Our research found that weight changes at diagnosis were associated with mortality in PD, with underweight or weight loss being linked to increased risk of death. Each person’s situation is different, so weight management should be tailored to each individual, considering their weight before they were diagnosed with PD.
Conflict of interest statement
The authors have no conflict of interest to report.
Figures
Similar articles
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester.BMC Womens Health. 2023 Jan 13;23(1):17. doi: 10.1186/s12905-023-02162-0. BMC Womens Health. 2023. PMID: 36635680 Free PMC article. Clinical Trial.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Chaudhuri KR, Healy DG and Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006; 5: 235–245. - PubMed
-
- Titova N, Qamar MA and Chaudhuri KR. The nonmotor features of Parkinson’s disease. Int Rev Neurobiol 2017; 132: 33–54. - PubMed
-
- van der Marck MA, Dicke HC, Uc EY, et al.. Body mass index in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord 2012; 18: 263–267. - PubMed
-
- De Lucia N, Peluso S, Esposito M, et al.. Frontal defect contribution to decreasing of body mass index in Parkinson’s disease patients. J Clin Neurosci 2020; 72: 229–232. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical